These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32152222)

  • 21. Patient-reported treatment-related symptom burden for patients with advanced melanoma in Canada.
    Cheung WY; White MK; Bayliss MS; Stroupe A; Lovley A; King-Kallimanis BL; Lasch K
    Support Care Cancer; 2019 Jan; 27(1):219-227. PubMed ID: 29934684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of New Primary Cutaneous Melanoma in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors: A Single-Center Cohort Study.
    Nanda JK; Dusza SW; Navarrete-Dechent C; Liopyris K; Marghoob AA; Marchetti MA
    JAMA Dermatol; 2021 Jan; 157(1):79-83. PubMed ID: 32936222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in long-term survivors of oropharynx carcinoma.
    Pourel N; Peiffert D; Lartigau E; Desandes E; Luporsi E; Conroy T
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):742-51. PubMed ID: 12377326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
    Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
    J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Single Center Survey of Health-Related Quality of Life among Acute Myeloid Leukemia Survivors in First Complete Remission.
    Cheng MJ; Smith BD; Hourigan CS; Gojo I; Pratz KW; Blackford AL; Mehta AK; Smith TJ
    J Palliat Med; 2017 Nov; 20(11):1267-1273. PubMed ID: 28537498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma.
    Regan MM; Werner L; Rao S; Gupte-Singh K; Hodi FS; Kirkwood JM; Kluger HM; Larkin J; Postow MA; Ritchings C; Sznol M; Tarhini AA; Wolchok JD; Atkins MB; McDermott DF
    J Clin Oncol; 2019 Dec; 37(35):3350-3358. PubMed ID: 31498030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom Severity and Quality of Life Among Long-term Colorectal Cancer Survivors Compared With Matched Control Subjects: A Population-Based Study.
    Hart TL; Charles ST; Gunaratne M; Baxter NN; Cotterchio M; Cohen Z; Gallinger S
    Dis Colon Rectum; 2018 Mar; 61(3):355-363. PubMed ID: 29377871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom experience and quality of life of women following breast cancer treatment.
    Janz NK; Mujahid M; Chung LK; Lantz PM; Hawley ST; Morrow M; Schwartz K; Katz SJ
    J Womens Health (Larchmt); 2007 Nov; 16(9):1348-61. PubMed ID: 18001192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion.
    Noorda EM; van Kreij RH; Vrouenraets BC; Nieweg OE; Muller M; Kroon BB; Aaronson NK
    Eur J Surg Oncol; 2007 Aug; 33(6):776-82. PubMed ID: 17300914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding quality of life issues in patients with advanced melanoma: Phase 1 and 2 in the development of the EORTC advanced melanoma module.
    Egeler MD; van Leeuwen M; Lai-Kwon J; Eriksson H; Bartula I; Elashwah S; Fox L; Van Hemelrijck M; Jefford M; Lijnsvelt J; Bagge AL; Morag O; Ny L; Olofsson Bagge R; Rogiers A; Saw RPM; Serpentini S; Iannopollo L; Thompson J; Stiller HT; Vanlaer N; van Akkooi ACJ; van de Poll-Franse LV;
    Eur J Cancer; 2024 Aug; 207():114176. PubMed ID: 38875843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
    Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
    PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health related quality of life in Turkish polio survivors: impact of post-polio on the health related quality of life in terms of functional status, severity of pain, fatigue, and social, and emotional functioning.
    Garip Y; Eser F; Bodur H; Baskan B; Sivas F; Yilmaz O
    Rev Bras Reumatol Engl Ed; 2017; 57(1):1-7. PubMed ID: 28137397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical activity and long-term fatigue among colorectal cancer survivors - a population-based prospective study.
    Eyl RE; Thong MSY; Carr PR; Jansen L; Koch-Gallenkamp L; Hoffmeister M; Chang-Claude J; Brenner H; Arndt V
    BMC Cancer; 2020 May; 20(1):438. PubMed ID: 32423448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressed mood in breast cancer survivors: associations with physical activity, cancer-related fatigue, quality of life, and fitness level.
    Galiano-Castillo N; Ariza-García A; Cantarero-Villanueva I; Fernández-Lao C; Díaz-Rodríguez L; Arroyo-Morales M
    Eur J Oncol Nurs; 2014 Apr; 18(2):206-10. PubMed ID: 24201014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors.
    Rogiers A; Boekhout A; Schwarze JK; Awada G; Blank CU; Neyns B
    J Oncol; 2019; 2019():5269062. PubMed ID: 31182961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol.
    Hyatt A; Gough K; Murnane A; Au-Yeung G; Dawson T; Pearson E; Dhillon H; Sandhu S; Williams N; Paton E; Billett A; Traill A; Andersen H; Beedle V; Milne D
    BMJ Open; 2020 Feb; 10(2):e036059. PubMed ID: 32114479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
    Mak KS; Smith AB; Eidelman A; Clayman R; Niemierko A; Cheng JS; Matthews J; Drumm MR; Nielsen ME; Feldman AS; Lee RJ; Zietman AL; Chen RC; Shipley WU; Milowsky MI; Efstathiou JA
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1028-1036. PubMed ID: 27727064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in head and neck cancer survivors: a cross-sectional survey.
    Chaukar DA; Walvekar RR; Das AK; Deshpande MS; Pai PS; Chaturvedi P; Kakade A; D'Cruz AK
    Am J Otolaryngol; 2009; 30(3):176-80. PubMed ID: 19410123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
    Larkin J; Chmielowski B; Lao CD; Hodi FS; Sharfman W; Weber J; Suijkerbuijk KPM; Azevedo S; Li H; Reshef D; Avila A; Reardon DA
    Oncologist; 2017 Jun; 22(6):709-718. PubMed ID: 28495807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
    O'Reilly A; Hughes P; Mann J; Lai Z; Teh JJ; Mclean E; Edmonds K; Lingard K; Chauhan D; Lynch J; Au L; Ludlow A; Pattison N; Wiseman T; Turajlic S; Gore M; Larkin J; Husson O
    Support Care Cancer; 2020 Feb; 28(2):561-570. PubMed ID: 31089820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.